HMMJ-U:CA:TSX-Global X Marijuana Life Sciences Index ETF (USD)

ETF | Others |

Last Closing

CAD 7.56

Change

0.00 (0.00)%

Market Cap

CAD 0.09B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.07 (+0.26%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.43%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.08 (-0.37%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.10 (-0.28%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.09%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.06 (-0.27%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.68B

ETFs Containing HMMJ-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.15% 43% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.15% 43% F 42% F
Trailing 12 Months  
Capital Gain 20.77% 60% D- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.77% 60% D- 59% D-
Trailing 5 Years  
Capital Gain -4.18% 21% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.18% 21% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 23.08% 97% N/A 86% B+
Dividend Return 23.10% 97% N/A 86% B+
Total Return 0.02% 16% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 60.26% 3% F 15% F
Risk Adjusted Return 38.34% 59% D- 56% F
Market Capitalization 0.09B 62% D 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.